Vcaps® Gen C is a high-quality capsule for pharmaceutical products based on a carrageenan gelling agent formulation.
Continuing to pioneer specialty polymer capsules, the Capsugel® HPMC portfolio gets enriched with Vcaps® Gen C Capsules, advancing the ability of pharmaceutical manufacturers to qualify a high-performing gelling agent-based capsule, with the Capsugel® high quality and performance standards.
Formulated to match current pharmaceutical products, aiming for a seamless qualification
Supports a dual sourcing strategy
Fast dissolution profile, pH independent without lag time, comparable to gelatin
Appealing looks, enabling patient acceptance and treatment compliance
Suitable for moisture sensitive formulations
Consistent quality and machinability
Reliable global distribution chain
Widest and most flexible production capacity
Manufactured with non-animal cellulose derivatives (HPMC)
Product formulation using carrageenan as gelling agent
The addition of Capsugel® Vcaps® Gen C broadens the already comprehensive HPMC product portfolio, providing solutions for immediate and modified release dosage forms. This new member of the vegan family will help pharmaceutical customers bring products to market faster, reliably.